Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cipla
Chubb
Covington
Julphar
AstraZeneca
Harvard Business School
Baxter
Dow
Fish and Richardson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Ipca Labs Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for IPCA LABS LTD, and what generic and branded alternatives to IPCA LABS LTD drugs are available?

IPCA LABS LTD has eighteen approved drugs.



Summary for Ipca Labs Ltd
US Patents:0
Tradenames:17
Ingredients:16
NDAs:18

Drugs and US Patents for Ipca Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ipca Labs Ltd ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 203761-001 Jan 23, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET;ORAL 078422-001 Aug 6, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd WARFARIN SODIUM warfarin sodium TABLET;ORAL 200104-002 Jun 27, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd WARFARIN SODIUM warfarin sodium TABLET;ORAL 200104-003 Jun 27, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd WARFARIN SODIUM warfarin sodium TABLET;ORAL 200104-005 Jun 27, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 201682-002 Mar 1, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 201682-003 Mar 1, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd FUROSEMIDE furosemide TABLET;ORAL 078010-001 Sep 18, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040766-001 Jun 14, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd FUROSEMIDE furosemide TABLET;ORAL 078010-002 Sep 18, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
Teva
UBS
Colorcon
QuintilesIMS
McKinsey
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot